N-(2-Carboxy-4,5-dichlorobenzoyl)-(+)-10,2-camphorsultam>98.0%(HPLC)(T)500mg

4-Bromo-2-ethylbenzoic acid, 99%, 5g

methyl 6-bromo-2-(propan-2-yl)-2H-indazole-4-carboxylate, 95.0%, 1g

(R)-5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, 95.0%, 5g

3-(4-(1,3-dioxoisoindolin-2-yl)butyl)-1H-indole-5-carbonitrile, 98%, 1g

(R)-3-tert-Butoxycarbonylamino-5-phenyl-pentanoic acid, 95.0%, 100mg

N-(4-Diethylaminophenyl)-2-chloropropanamide, 95%, 10g

4-Cyanophenyl 4-Heptylbenzoate>98.0%(GC)1g

2-Hydroxy-5-nitrobenzyl Alcohol>98.0%(GC)5g

Methyl 5-bromo-2-methyl-3-(trifluoromethyl)benzoate, 98%, 5g

1-(tert-Butoxycarbonyl)-3-(hydroxymethyl)piperazine>98.0%(GC)(T)1g

Sodium bromodifluoroacetate, 95%, 100g

NBD-Cl (=4-Chloro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling]>98.0%(T)5g